CI:NYE-Cigna Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 337.83

Change

+1.36 (+0.40)%

Market Cap

USD 35.85B

Volume

1.51M

Analyst Target

USD 242.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cigna Corp is a health services organization. The Company provides medical, dental, disability, life and accident insurance and related products and services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 455.93B
ELV Elevance Health Inc

N/A

USD 125.26B
CVS CVS Health Corp

N/A

USD 76.20B
HUM Humana Inc

N/A

USD 42.39B
CNC Centene Corp

N/A

USD 37.96B
MOH Molina Healthcare Inc

N/A

USD 18.18B
OSCR Oscar Health Inc

N/A

USD 4.63B
NEUE NeueHealth Inc

N/A

USD 0.05B

ETFs Containing CI

IHF iShares U.S. Healthcare P.. 9.06 % 0.43 %

N/A

USD 0.76B
PINK Simplify Exchange Traded .. 5.71 % 0.00 %

N/A

USD 0.12B
FHI:CA CI Health Care Giants Cov.. 5.32 % 0.75 %

N/A

CAD 0.09B
AILV 4.45 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.57 % 0.00 %

N/A

USD 0.78B
CBUF:F iShares V Public Limited .. 3.29 % 0.00 %

N/A

USD 1.13B
PVAL Putnam Focused Large Cap .. 2.73 % 0.29 %

N/A

USD 0.62B
FSST Fidelity Sustainability U.. 2.71 % 0.00 %

N/A

USD 0.01B
NSCR Nuveen Sustainable Core E.. 2.09 % 0.00 %

N/A

USD 5.49M
FXH First Trust Health Care A.. 2.05 % 0.63 %

N/A

USD 1.23B
IQSA:LSE Invesco Quantitative Stra.. 1.55 % 0.00 %

N/A

USD 0.34B
IQSA:F Invesco Markets II PLC - .. 1.53 % 0.00 %

N/A

N/A
IQSE:F Invesco Markets II PLC - .. 1.53 % 0.00 %

N/A

N/A
IS07:F iShares IV Public Limited.. 1.50 % 0.00 %

N/A

N/A
IS07:XETRA iShares Edge MSCI World M.. 1.50 % 0.00 %

N/A

USD 0.01B
DMFC:SW iShares Edge MSCI World M.. 1.50 % 0.00 %

N/A

USD 7.39M
IFSW:SW iShares Edge MSCI World M.. 1.50 % 0.00 %

N/A

USD 0.53B
CSY9:XETRA Credit Suisse Index Fund .. 1.48 % 0.00 %

N/A

USD 0.29B
IBCZ:F iShares IV Public Limited.. 1.44 % 0.00 %

N/A

USD 0.46B
IBCZ:XETRA iShares Edge MSCI World M.. 1.44 % 0.00 %

N/A

USD 0.40B
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.02B
FHH:CA First Trust AlphaDEX US H.. 0.00 % 0.77 %

N/A

CAD 9.66M
FUM:CA 0.00 % 0.80 %

N/A

N/A
QSY 0.00 % 0.38 %

N/A

N/A
HONR 0.00 % 0.65 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

USD 0.05B
RYH 0.00 % 0.40 %

N/A

N/A
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

N/A

USD 0.12B
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

N/A

CAD 0.36B
XXM:CA 0.00 % 0.68 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

N/A

CAD 0.29B
FSWD:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

USD 0.53B
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

N/A

USD 4.24B
BUYB:PA Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

USD 0.05B
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 7.90M
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.33B
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.25B
BBCK:F Invesco Markets III plc -.. 0.00 % 0.00 %

N/A

USD 0.05B
BBCK:XETRA Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

USD 0.05B
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.40B
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.49B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.05B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
IQSA:XETRA Invesco Quantitative Stra.. 0.00 % 0.00 %

N/A

USD 0.07B
IQSE:XETRA Invesco Quantitative Stra.. 0.00 % 0.00 %

N/A

USD 0.05B
HDIV 0.00 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

N/A

USD 1.13B
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B
STNC Stance Equity ESG Large C.. 0.00 % 0.00 %

N/A

USD 0.11B
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

N/A

CAD 0.08B
FDWM Fidelity Covington Trust .. 0.00 % 0.00 %

N/A

USD 4.40M
NTZG Nuveen Global Net Zero Tr.. 0.00 % 0.00 %

N/A

USD 6.35M
BUYB:SW Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.82% 75% C 83% B
Dividend Return 0.47% 80% B- 24% F
Total Return 13.28% 75% C 82% B
Trailing 12 Months  
Capital Gain 36.73% 88% B+ 85% B
Dividend Return 2.06% 80% B- 29% F
Total Return 38.79% 88% B+ 85% B
Trailing 5 Years  
Capital Gain 126.00% 83% B 88% B+
Dividend Return 9.93% 50% F 36% F
Total Return 135.93% 83% B 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.26% 63% D 80% B-
Dividend Return 16.56% 63% D 79% B-
Total Return 1.31% 60% D- 32% F
Risk Return Profile  
Volatility (Standard Deviation) 18.26% 88% B+ 60% D-
Risk Adjusted Return 90.72% 75% C 97% N/A
Market Capitalization 35.85B 78% C+ 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.60 29% 27%
Price/Book Ratio 2.15 75% 40%
Price / Cash Flow Ratio 8.02 56% 47%
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity 8.97% 33% 53%
Return on Invested Capital 6.56% 56% 51%
Return on Assets 3.08% 33% 56%
Debt to Equity Ratio 60.91% 56% 54%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.